Prostatic Neoplasms: all 6,484 studies
Page 62 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting OsteoporosisCompletedNCT00171639Phase 3
- Registry and Database Lap ProstatectomyCompletedNCT00169676
- Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate CancerCompletedNCT00167648Phase 2
- Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical OutcomeStatus unknownNCT00167024
- Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer PatientsCompletedNCT00166725Phase 2
- Exisulind Prior to Radical ProstatectomyCompletedNCT00166478Phase 2
- Exisulind Versus Placebo After Surgical Removal of the ProstateCompletedNCT00166426Phase 2
- Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local TreatmentCompletedNCT00165399Phase 2
- MRI-guided Bone Marrow Biopsies of Prostate Cancer PatientsCompletedNCT00165386Not applicable
- CD-ROM Intervention for Prostate Cancer ScreeningCompletedNCT00164437Phase 2/3
- Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among ElderlyWithdrawnNCT00161252
- Transrectal Tumour Oxygen - US ArmyCompletedNCT00160979Phase 2
- Endorectal Coil Magnetic Resonance Images (ERC-MRI)CompletedNCT00160953Phase 2
- A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate CancerCompletedNCT00156884Phase 2
- Family History in Prostate Cancer Patients in TaiwanStatus unknownNCT00155025
- Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate BrachytherapyCompletedNCT00152919Phase 3
- Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate BiopsyCompletedNCT00152789Phase 2
- Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate CancerCompletedNCT00151086Phase 1/2
- Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the ProstateCompletedNCT00151073Phase 2
- Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate CancerCompletedNCT00151047Phase 2
- Tetrathiomolybdate in Hormone Refractory Prostate CancerCompletedNCT00150995Phase 2
- Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSACompletedNCT00148928Phase 1
- Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone TherapyCompletedNCT00148772Phase 2
- Mifepristone (RU-486) in Androgen Independent Prostate CancerCompletedNCT00140478Phase 2
- Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate CancerCompletedNCT00140400Phase 1/2
- Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)CompletedNCT00140387Phase 1/2
- Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)CompletedNCT00140374Phase 1/2
- Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer VaccineCompletedNCT00140348Phase 1/2
- Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer PatientsCompletedNCT00139204Not applicable
- Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate CancerCompletedNCT00139191Not applicable
- Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate CancerCompletedNCT00138918Phase 2
- Psychostimulants for Fatigue in Prostate CancerCompletedNCT00138138Phase 2
- Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical ProstatectomyCompletedNCT00138008Phase 3
- Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate CancerCompletedNCT00136526Phase 2
- Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate CancerCompletedNCT00136487Phase 2/3
- A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate CancerCompletedNCT00134706Phase 2
- Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate CancerCompletedNCT00134654Phase 2
- Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate CancerCompletedNCT00134355Phase 2
- Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving ChemotherapyStatus unknownNCT00133900
- Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer PatientsTerminatedNCT00133224Phase 3
- Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate CancerTerminatedNCT00132756Phase 1/2
- Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyCompletedNCT00129142Phase 3
- Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate CancerCompletedNCT00129025Phase 1/2
- Leuprolide Acetate 3.75 mg Depot to Treat Prostate CancerCompletedNCT00128531Phase 3
- Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant TherapyCompletedNCT00127816Not applicable
- A Long Term Safety Study With AtrasentanCompletedNCT00127478Phase 2/3
- Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their ConfidantsCompletedNCT00127465Phase 1/2
- Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and CachexiaTerminatedNCT00127387Phase 2/3
- Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer PatientsSuspendedNCT00127088Phase 2
- High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy ImplantationCompletedNCT00126854Not applicable
- Mathematical Modeling Analysis of Serum Prostate Specific Antigen After RadiotherapyCompletedNCT00126815
- The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate CancerStatus unknownNCT00126802Phase 1/2
- Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate CancerTerminatedNCT00126230Phase 2
- Short-course Hypofractionated Radiotherapy for Localized Prostate CancerCompletedNCT00126165Phase 1/2
- Study of Irofulven in Patients With Hormone-refractory Prostate CancerCompletedNCT00124566Phase 2
- Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal ManipulationCompletedNCT00124410
- Positioning and Tracking the Prostate During External Beam RadiationCompletedNCT00123838Not applicable
- A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate CancerCompletedNCT00122499Phase 3
- Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate CancerTerminatedNCT00122265
- Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose EscalationTerminatedNCT00122252
- GVAX in Advanced Prostate Cancer Patients Made LymphopenicStatus unknownNCT00122005Phase 1/2
- Positron Emission Tomography in Prostate CancerCompletedNCT00121212Not applicable
- Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate CancerStatus unknownNCT00121095Phase 1/2
- Study of Motexafin Gadolinium and Docetaxel for Advanced CancerCompletedNCT00120939Phase 1
- Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial NeoplasiaTerminatedNCT00118066Phase 2
- Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate CancerCompletedNCT00116220Phase 3
- Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate CancerCompletedNCT00116155Phase 1/2
- Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate CancerCompletedNCT00115635Phase 1/2
- Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal BleedingCompletedNCT00114985Phase 2
- Vaccine and Antibody Treatment of Prostate CancerCompletedNCT00113984Phase 1
- Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate CancerCompletedNCT00111618Phase 2
- Gene Therapy for Prostate Cancer That Returns After Radiation TherapyWithdrawnNCT00110526Phase 1
- Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)CompletedNCT00110188Phase 2
- Androgen Deprivation Therapy in Treating Patients With Prostate CancerStatus unknownNCT00110162Phase 3
- Vaccine Therapy in Treating Patients With Recurrent Prostate CancerCompletedNCT00109811Phase 2
- Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate CancerCompletedNCT00108290Phase 2
- Tumor RNA Transfected Dendritic Cell VaccinesCompletedNCT00108264Phase 1
- A Research Study for Patients With Prostate CancerCompletedNCT00106418Phase 2
- Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228CompletedNCT00106301Phase 2
- Vaccine Treatment for Hormone Refractory Prostate CancerCompletedNCT00105053Phase 1/2
- Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00104741Phase 3
- Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate CancerCompletedNCT00104715Phase 3
- Study of KOS-862 (Epothilone D) in Metastatic Prostate CancerTerminatedNCT00104130Phase 2
- The Plenaxis® Experience StudySuspendedNCT00103623Phase 4
- Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate CancerTerminatedNCT00103428Phase 1/2
- Cilengitide in Treating Patients With Metastatic Prostate CancerCompletedNCT00103337Phase 2
- Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist TherapyCompletedNCT00100243Phase 2
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00099086Phase 1
- A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive TherapyCompletedNCT00096551Phase 1
- SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or PaclitaxelCompletedNCT00096499Phase 2
- Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate CancerTerminatedNCT00096304Phase 1
- Lapatinib in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT00095667Phase 2
- Lycopene in Preventing Prostate Cancer in Healthy ParticipantsCompletedNCT00093561Phase 1
- Sorafenib in Treating Patients With Metastatic or Recurrent Prostate CancerCompletedNCT00093457Phase 2
- Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing ProstatectomyCompletedNCT00090376Phase 2
- GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerTerminatedNCT00089856Phase 3
- Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
- Study of Individualized Amonafide to Treat Prostate CancerCompletedNCT00087854Phase 1/2
- A Prostate Cancer Study in Men Undergoing Androgen Deprivation TherapyCompletedNCT00087659Not applicable
- Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast CancerCompletedNCT00087347